Kimia Kashef, Ph.D.
Affiliations: | 2006 | Temple University, Philadelphia, PA, United States |
Area:
Molecular BiologyGoogle:
"Kimia Kashef"Parents
Sign in to add mentorDanny Dhanasekaran | grad student | 2006 | Temple University | |
(Novel interaction between G12 family of G proteins and JNK scaffolding protein JLP.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jordan K, Gralla R, Rizzi G, et al. (2016) Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimens. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer |
Natale JJ, Spinelli T, Calcagnile S, et al. (2015) Drug-drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical data. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners |
Kashef K, Radhakrishnan R, Lee CM, et al. (2011) Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein. Neoplasia (New York, N.Y.). 13: 358-64 |
Dhanasekaran DN, Kashef K, Lee CM, et al. (2007) Scaffold proteins of MAP-kinase modules. Oncogene. 26: 3185-202 |
Kashef K, Xu H, Reddy EP, et al. (2006) Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. Journal of Cellular Biochemistry. 98: 715-22 |
Kashef K, Lee CM, Ha JH, et al. (2005) JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry. 44: 14090-6 |